Evidence map›Paper›PMID 34940567›Full record

ArticleMetabolites2021

Prognostic Value of Pretherapeutic Primary Tumor MTV from [

Paulina Cegla, Frank Hofheinz, Witold Cholewiński, Rafał Czepczyński, Anna Kubiak, Jörg van den Hoff, Agnieszka Boś-Liedke, Andrzej Roszak, Ewa Burchardt

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Metabolites, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Asphericity derived from [Scientific reports · 2023
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Paulina CeglaDepartment of Nuclear Medicine, Greater Poland Cancer Centre, 61-866 Poznań, Poland.ORCID 0000-0002-6676-3436
Frank HofheinzHelmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, 01328 Dresden, Germany.
Witold CholewińskiDepartment of Nuclear Medicine, Greater Poland Cancer Centre, 61-866 Poznań, Poland.
Rafał CzepczyńskiDepartment of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, 61-701 Poznań, Poland.ORCID 0000-0003-0684-1647
Anna KubiakGreater Poland Cancer Registry, Greater Poland Cancer Centre, 61-866 Poznań, Poland.
Jörg van den HoffHelmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, 01328 Dresden, Germany.
Agnieszka Boś-LiedkeDepartment of Macromolecular Physics, Adam Mickiewicz University, 61-614 Poznań, Poland.ORCID 0000-0002-4009-0501
Andrzej RoszakDepartment of Electroradiology, Poznan University of Medical Sciences, 61-701 Poznań, Poland.
Ewa BurchardtDepartment of Electroradiology, Poznan University of Medical Sciences, 61-701 Poznań, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to assess the usefulness of pretherapeutic primary tumor metabolic tumor volume (MTV) in the prognosis of radically treated cervical cancer patients. Retrospective, single-centre analysis was performed on a group of 508 cervical cancer patients. All patients underwent a pretreatment [

Indexed as

[18F]FDGcervical cancermetabolic parameterspositron emission tomography/computed tomography

Identifiers

PMID34940567
PMCPMC8706993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.